Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM)
- 15 November 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (10) , 3850-3851
- https://doi.org/10.1182/blood-2003-08-2654
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trialLeukemia, 2003
- Heterozygous PU.1 mutations are associated with acute myeloid leukemiaBlood, 2003
- Heterozygous PU.1 mutations are associated with acute myeloid leukemiaBlood, 2002
- C/EBP-β, C/EBP-δ, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignanciesLeukemia Research, 2002
- Transcription Factors, Normal Myeloid Development, and LeukemiaBlood, 1997